W.‐K. Hofmann

Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)

Benjamin Hanfstein, Marc Müller, Rüdiger Hehlmann et al. · Leukemia · 2012 · 416 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Health Sciences +10

Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V+ advanced systemic mastocytosis

Mohamad Jawhar, Juliana Schwaab, Susanne Schnittger et al. · Leukemia · 2015 · 218 citations

Additional Mutations, Mast Cell Disorder, Systemic Mastocytosis +7

Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event

Mohamad Jawhar, Juliana Schwaab, Susanne Schnittger et al. · Leukemia · 2015 · 149 citations

Immunogenetics, Medicine, Mast Cell Disorder +11

Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies.

Takayuki Ikezoe, Miller Cw, Seiji Kawano et al. · PubMed · 2001 · 140 citations

Pathology, Cancer Biology, Tumor Biology +18

Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib

Benjamin Hanfstein, Valeria Shlyakhto, Michael Lauseker et al. · Leukemia · 2014 · 135 citations

Chronic Phase, Hematological Malignancy, Chronic Myeloid Leukemia +10